Corpus Intelligence IC Memo — ADVENTHEALTH ORLANDO 2026-04-26 02:11 UTC
IC Memo — ADVENTHEALTH ORLANDO
Investment Committee Memorandum | FL | 2738 beds | Grade B | EBITDA uplift $397.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ADVENTHEALTH ORLANDO

CCN 100007 | nan, FL | 2738 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

ADVENTHEALTH ORLANDO is a 2738-bed large academic medical center in nan, FL with $5.40B in net patient revenue and a 2.5% operating margin. The hospital serves a payer mix of 21.9% Medicare, 4.9% Medicaid, and 73.1% commercial.

Thesis: Undervalued. Our ML models identify $397.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.5% to 9.8% (+736bps).

Net Revenue HCRIS$5.40B
Current EBITDA COMPUTED$133.6M
Operating Margin COMPUTED2.5%
Occupancy HCRIS80.0%
Revenue / Bed COMPUTED$2.0M
Net-to-Gross HCRIS19.7%
Distress Probability ML47.7%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
10
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 2.5% places it below the state median. Among 10 size-comparable peers (1369-5476 beds), the median margin is -4.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (1369-5476), prioritizing same-state peers. 10 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ADVENTHEALTH ORLANDO (Target)FL2738$5.40B2.5%
NEW YORK PRESBYTERIAN HOSPITALNY2850$7.69B-1.4%
NYU LANGONE HOSPITALSNY1618$7.24B-7.8%
MONTEFIORE MEDICAL CENTERNY1410$3.01B-50.0%
NORTON HOSPITALS INCKY1479$2.59B2.0%
METHODIST HOSPITALTX1729$2.42B22.9%
ORLANDO HEALTHFL1507$2.38B-20.2%
MEMORIAL HERMANN HOSPITAL SYSTX1417$2.15B7.3%
JACKSON MEMORIALFL1893$1.47B-50.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $397.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$113.5M+210bp18mo
Cost to Collect4.5%2.5%$108.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$107.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$65.7M+122bp9mo
Clean Claim Rate88.0%96.0%$3.5M+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$113.5M
Cost to Collect
$108.1M
Denial Rate Reduction
$107.0M
A/R Days Reduction
$65.7M
Clean Claim Rate
$3.5M
Total EBITDA Uplift$397.7M
Current EBITDA$133.6M
+ RCM Uplift+$397.7M
Pro Forma EBITDA$531.4M
Current Margin2.5%
Pro Forma Margin9.8%
WC Released (1x)$207.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$205.6M$4.86B23.63x88.2%
Base (11x exit)10.0x11.0x$205.6M$5.41B26.32x92.3%
Bull Case9.0x11.0x$185.1M$6.79B36.70x105.6%
Bull (12x exit)9.0x12.0x$185.1M$7.46B40.33x109.5%
Bear Case11.0x10.0x$226.2M$2.80B12.39x65.4%
Bear (11x exit)11.0x11.0x$226.2M$3.16B13.96x69.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 10 hospitals with 1369-5476 beds
  • Same-state prioritization (n=3)
  • Comp margins: P25=-42.6% / P50=-4.6% / P75=5.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.